BD and Scanwell Health, a smartphone-enabled at-home medical tests developer, have announced a partnership to develop an at-home rapid test for detecting the SARS-CoV-2 virus. The rapid test will utilise BD’s lateral flow antigen test and pair it with Scanwell’s mobile app to collect and transfer nasal swab samples and analyse the results.
COPAN Diagnostics has shipped more than 15 million Covid-19 sample collection kits across the US, after receiving $10m from Apple’s Advanced Manufacturing Fund. Apple, COPAN, and other US companies have collaborated to create and develop new machinery for COPAN’s Southern California facilities, which will have ultimately led to an increase in test-kit production by around 4,000% since April.
BioReference Laboratories is participating in the NY Forward Rapid Testing Programme by opening eight locations for Covid-19 rapid testing in New York. The programme is designed to offer New Yorkers, and those visiting, inexpensive rapid Covid-19 testing.
LightDeck Diagnostics has been awarded a $5.65m contract from the US Biomedical Advanced Research and Development Authority (BARDA) to develop a portable, rapid antigen test that can detect the SARS-CoV-2 virus. The funds will help LightDeck to developing a point-of-care antigen test that can deliver results in less than six minutes.
